5th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today

Saturday, March 23, 2024, 7:30 AM - 12:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA


The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.

1. Consider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers
2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
4. Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
5. Identify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents
6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

---

In-Person Fees
In-person-Physicians: $49
In-person-Non-physician: Free
In-person-Resident/Fellow: Free
In-person-Industry: $99.00

Vitual Fees
Virtual-Physicians: $99
Virtual- Non-physicians: Free
Virtual-Resident/Fellow: Free

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.

---

Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocols
As you know, the health and safety of our community are always our top priorities at Cedars-Sinai. Participants in any event should be thoughtful about their individual risks and consider avoiding public gatherings if they are of higher risk.

Click here to review the current in-person Cedars-Sinai CME Event Protocols.

---

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

 

ANCC Credit
Cedars-Sinai designates this activity for a maximum of 4.50 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

 

American Board of Internal Medicine (ABIM) MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

How do you get the MOC Points?
Before earning any MOC points, you must:

 

•  Log into your account in the CME Portal (https://cedars.cloud-cme.com/)
• Update your profile with your board diplomate number and date of birth.
• Points will not be awarded retrospectively.

AMA PRA Category 1 Credit(s)™ (MD, DO) (4.50 hours), ABIM MOC Part 2 (4.50 hours), ANCC (4.50 hours), Non-Physician AMA Attendance (4.50 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, March 23, 2024

2024 GI TUMOR-Exhibitors by Cedars-Sinai CME

GI Tumor-Exhibitors by Cedars-Sinai CME